Ping An Biomedical’s total Assets stood at RMB100,222,250 on March 31, 2026, up from RMB68,414,527 in the earlier balance-sheet column. Equity investments accounted for RMB41,246,798, while current assets were RMB55,910,772. The figures show the composition of the group’s interim Balance Sheet for investors reviewing its financial position.

Key Highlights

  • Equity investments reached RMB41,246,798 at March 31, 2026, compared with none in the earlier balance-sheet column.
  • Cash and bank balances were RMB6,842,381, while restricted cash stood at RMB29,144,050.
  • Current liabilities totaled RMB22,040,208, including RMB10,000,000 in short-term bank borrowings.

Ping An Biomedical Co. Ltd. (NASDAQ: PASW) reported total assets of RMB100,222,250 at March 31, 2026, compared with RMB68,414,527 in the earlier balance-sheet column. The first-half 2026 unaudited financial results also showed total current assets of RMB55,910,772 and total non-current assets of RMB44,311,478. The balance sheet included RMB41,246,798 in equity investments.

Equity Investments Reach RMB41.2M

Equity investments stood at RMB41,246,798 at March 31, 2026, compared with none in the earlier balance-sheet column. Right-of-use assets were RMB272,911, while deferred tax assets, net, totaled RMB2,791,769. Current assets included cash and bank balances of RMB6,842,381. Restricted cash was RMB29,144,050, accounts receivable, net, was RMB6,188,887, and deposits, prepayments and other receivables came to RMB13,735,454. Inventories were zero. The earlier balance-sheet column showed cash and bank balances of RMB1,172,480, restricted cash of RMB35,523,810, accounts receivable, net, of RMB16,930,876, deposits, prepayments and other receivables of RMB9,628,377, and inventories of RMB441,904.

Liabilities Total RMB22.0M

Total liabilities were RMB22,040,208 at March 31, 2026. Short-term bank borrowings were RMB10,000,000, the same amount shown in the earlier balance-sheet column. Accounts Payable declined to RMB1,618,011 from RMB9,413,410 in the earlier balance-sheet column. Accruals and other payables were RMB7,111,360, while other payables to related parties were RMB3,037,926. Contract liabilities were zero, and current Lease liabilities were RMB272,911. The earlier balance-sheet column showed accruals and other payables of RMB287,674, other payables to related parties of RMB2,934,083, contract liabilities of RMB69,776, and current lease liabilities of RMB371,879. Non-current lease liabilities were zero at March 31, 2026.

Cash and Receivables

The balance sheet reported total current assets of RMB55,910,772 and total non-current assets of RMB44,311,478. Total assets were RMB100,222,250 at March 31, 2026. The balance sheet reported cash and bank balances of RMB6,842,381, restricted cash of RMB29,144,050, Accounts Receivable of RMB6,188,887 and other receivables of RMB13,735,454. Ping An Biomedical’s earlier balance-sheet column recorded total current assets of RMB63,697,447 and total non-current assets of RMB4,717,080. Total liabilities in that column were RMB23,172,520.